Be Biopharma Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
84
- Latest Deal Type
-
Out of Business
Be Biopharma General Information
Description
Developer of engineered B-cell medicines intended to transform treatment for patients with serious diseases. The company's drugs address major hurdles of cell and gene therapies and are durable, re-enable, and can be administered without toxic conditioning, enabling healthcare professionals to treat diseases like cancer, autoimmune conditions, and enzyme deficiency while providing targeted, effective care for patients.
Contact Information
Website
www.be.bioCorporate Office
- One Kendall Square
- B200, Third Floor
- Cambridge, MA 02139
- United States
Corporate Office
- One Kendall Square
- B200, Third Floor
- Cambridge, MA 02139
- United States
Be Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 05-Oct-2026 | Completed | Out of Business | |||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series C) | 01-Oct-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 14-Apr-2022 | $130M | $182M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 22-Oct-2020 | $52M | $52M | Completed | Generating Revenue |
Be Biopharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Be Biopharma Comparisons
Industry
Financing
Details
Be Biopharma Competitors (23)
One of Be Biopharma’s 23 competitors is Immusoft, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immusoft | Venture Capital-Backed | Seattle, WA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Ayala Pharmaceuticals | Corporation | Wilmington, DE | ||||
| Allogene Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA |
Be Biopharma Patents
Be Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025240349-A2 | Allogeneic cell compositions and methods thereof | Pending | 15-May-2024 | ||
| WO-2025240349-A3 | Allogeneic cell compositions and methods thereof | Pending | 15-May-2024 | ||
| WO-2025240349-A8 | Allogeneic cell compositions and methods thereof | Pending | 15-May-2024 | ||
| AU-2024369860-A1 | Engineered cell preparations for treatment of hypophosphatasia | Pending | 02-Nov-2023 | ||
| EP-4801522-A2 | Engineered cell preparations for treatment of hypophosphatasia | Pending | 02-Nov-2023 | C12N9/16 |
Be Biopharma Signals
Be Biopharma FAQs
-
When was Be Biopharma founded?
Be Biopharma was founded in 2020.
-
Where is Be Biopharma headquartered?
Be Biopharma is headquartered in Cambridge, MA.
-
What is the size of Be Biopharma?
Be Biopharma has 84 total employees.
-
What industry is Be Biopharma in?
Be Biopharma’s primary industry is Drug Discovery.
-
Is Be Biopharma a private or public company?
Be Biopharma is a Private company.
-
What is Be Biopharma’s current revenue?
The current revenue for Be Biopharma is .
-
How much funding has Be Biopharma raised over time?
Be Biopharma has raised $274M.
-
Who are Be Biopharma’s competitors?
Immusoft, Sangamo Therapeutics, Ayala Pharmaceuticals, Allogene Therapeutics, and Kite Pharma are some of the 23 competitors of Be Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process